Table of Content

1 Medicine for Osteoarthritis Pain Market Overview
1.1 Product Overview and Scope of Medicine for Osteoarthritis Pain
1.2 Medicine for Osteoarthritis Pain Segment by Type
1.2.1 Global Medicine for Osteoarthritis Pain Market Value Comparison by Type (2024-2034)
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Medicine for Osteoarthritis Pain Segment by Application
1.3.1 Global Medicine for Osteoarthritis Pain Market Value by Application: (2024-2034)
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Global Medicine for Osteoarthritis Pain Market Size Estimates and Forecasts
1.4.1 Global Medicine for Osteoarthritis Pain Revenue 2018-2034
1.4.2 Global Medicine for Osteoarthritis Pain Sales 2018-2034
1.4.3 Global Medicine for Osteoarthritis Pain Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Medicine for Osteoarthritis Pain Market Competition by Manufacturers
2.1 Global Medicine for Osteoarthritis Pain Sales Market Share by Manufacturers (2018-2023)
2.2 Global Medicine for Osteoarthritis Pain Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Medicine for Osteoarthritis Pain Average Price by Manufacturers (2018-2023)
2.4 Global Medicine for Osteoarthritis Pain Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Medicine for Osteoarthritis Pain, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medicine for Osteoarthritis Pain, Product Type & Application
2.7 Medicine for Osteoarthritis Pain Market Competitive Situation and Trends
2.7.1 Medicine for Osteoarthritis Pain Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medicine for Osteoarthritis Pain Players Market Share by Revenue
2.7.3 Global Medicine for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medicine for Osteoarthritis Pain Retrospective Market Scenario by Region
3.1 Global Medicine for Osteoarthritis Pain Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Medicine for Osteoarthritis Pain Global Medicine for Osteoarthritis Pain Sales by Region: 2018-2034
3.2.1 Global Medicine for Osteoarthritis Pain Sales by Region: 2018-2023
3.2.2 Global Medicine for Osteoarthritis Pain Sales by Region: 2024-2034
3.3 Global Medicine for Osteoarthritis Pain Global Medicine for Osteoarthritis Pain Revenue by Region: 2018-2034
3.3.1 Global Medicine for Osteoarthritis Pain Revenue by Region: 2018-2023
3.3.2 Global Medicine for Osteoarthritis Pain Revenue by Region: 2024-2034
3.4 North America Medicine for Osteoarthritis Pain Market Facts & Figures by Country
3.4.1 North America Medicine for Osteoarthritis Pain Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Medicine for Osteoarthritis Pain Sales by Country (2018-2034)
3.4.3 North America Medicine for Osteoarthritis Pain Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Medicine for Osteoarthritis Pain Market Facts & Figures by Country
3.5.1 Europe Medicine for Osteoarthritis Pain Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Medicine for Osteoarthritis Pain Sales by Country (2018-2034)
3.5.3 Europe Medicine for Osteoarthritis Pain Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medicine for Osteoarthritis Pain Market Facts & Figures by Country
3.6.1 Asia Pacific Medicine for Osteoarthritis Pain Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Medicine for Osteoarthritis Pain Sales by Country (2018-2034)
3.6.3 Asia Pacific Medicine for Osteoarthritis Pain Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Medicine for Osteoarthritis Pain Market Facts & Figures by Country
3.7.1 Latin America Medicine for Osteoarthritis Pain Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Medicine for Osteoarthritis Pain Sales by Country (2018-2034)
3.7.3 Latin America Medicine for Osteoarthritis Pain Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medicine for Osteoarthritis Pain Market Facts & Figures by Country
3.8.1 Middle East and Africa Medicine for Osteoarthritis Pain Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Medicine for Osteoarthritis Pain Sales by Country (2018-2034)
3.8.3 Middle East and Africa Medicine for Osteoarthritis Pain Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medicine for Osteoarthritis Pain Sales by Type (2018-2034)
4.1.1 Global Medicine for Osteoarthritis Pain Sales by Type (2018-2023)
4.1.2 Global Medicine for Osteoarthritis Pain Sales by Type (2024-2034)
4.1.3 Global Medicine for Osteoarthritis Pain Sales Market Share by Type (2018-2034)
4.2 Global Medicine for Osteoarthritis Pain Revenue by Type (2018-2034)
4.2.1 Global Medicine for Osteoarthritis Pain Revenue by Type (2018-2023)
4.2.2 Global Medicine for Osteoarthritis Pain Revenue by Type (2024-2034)
4.2.3 Global Medicine for Osteoarthritis Pain Revenue Market Share by Type (2018-2034)
4.3 Global Medicine for Osteoarthritis Pain Price by Type (2018-2034)
5 Segment by Application
5.1 Global Medicine for Osteoarthritis Pain Sales by Application (2018-2034)
5.1.1 Global Medicine for Osteoarthritis Pain Sales by Application (2018-2023)
5.1.2 Global Medicine for Osteoarthritis Pain Sales by Application (2024-2034)
5.1.3 Global Medicine for Osteoarthritis Pain Sales Market Share by Application (2018-2034)
5.2 Global Medicine for Osteoarthritis Pain Revenue by Application (2018-2034)
5.2.1 Global Medicine for Osteoarthritis Pain Revenue by Application (2018-2023)
5.2.2 Global Medicine for Osteoarthritis Pain Revenue by Application (2024-2034)
5.2.3 Global Medicine for Osteoarthritis Pain Revenue Market Share by Application (2018-2034)
5.3 Global Medicine for Osteoarthritis Pain Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Medicine for Osteoarthritis Pain Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Johnson and Johnson
6.2.1 Johnson and Johnson Corporation Information
6.2.2 Johnson and Johnson Description and Business Overview
6.2.3 Johnson and Johnson Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Johnson and Johnson Medicine for Osteoarthritis Pain Product Portfolio
6.2.5 Johnson and Johnson Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
6.3.4 GlaxoSmithKline Medicine for Osteoarthritis Pain Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bayer Medicine for Osteoarthritis Pain Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Eli Lilly
6.5.1 Eli Lilly Corporation Information
6.5.2 Eli Lilly Description and Business Overview
6.5.3 Eli Lilly Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Eli Lilly Medicine for Osteoarthritis Pain Product Portfolio
6.5.5 Eli Lilly Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Novartis Medicine for Osteoarthritis Pain Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanofi Medicine for Osteoarthritis Pain Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Horizon Pharma
6.8.1 Horizon Pharma Corporation Information
6.8.2 Horizon Pharma Description and Business Overview
6.8.3 Horizon Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Horizon Pharma Medicine for Osteoarthritis Pain Product Portfolio
6.8.5 Horizon Pharma Recent Developments/Updates
6.9 Abbott
6.9.1 Abbott Corporation Information
6.9.2 Abbott Description and Business Overview
6.9.3 Abbott Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Abbott Medicine for Osteoarthritis Pain Product Portfolio
6.9.5 Abbott Recent Developments/Updates
6.10 Mylan
6.10.1 Mylan Corporation Information
6.10.2 Mylan Description and Business Overview
6.10.3 Mylan Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Mylan Medicine for Osteoarthritis Pain Product Portfolio
6.10.5 Mylan Recent Developments/Updates
6.11 Daiichi Sankyo
6.11.1 Daiichi Sankyo Corporation Information
6.11.2 Daiichi Sankyo Medicine for Osteoarthritis Pain Description and Business Overview
6.11.3 Daiichi Sankyo Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Daiichi Sankyo Medicine for Osteoarthritis Pain Product Portfolio
6.11.5 Daiichi Sankyo Recent Developments/Updates
6.12 TEVA
6.12.1 TEVA Corporation Information
6.12.2 TEVA Medicine for Osteoarthritis Pain Description and Business Overview
6.12.3 TEVA Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
6.12.4 TEVA Medicine for Osteoarthritis Pain Product Portfolio
6.12.5 TEVA Recent Developments/Updates
6.13 Almatica Pharma
6.13.1 Almatica Pharma Corporation Information
6.13.2 Almatica Pharma Medicine for Osteoarthritis Pain Description and Business Overview
6.13.3 Almatica Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Almatica Pharma Medicine for Osteoarthritis Pain Product Portfolio
6.13.5 Almatica Pharma Recent Developments/Updates
6.14 Astellas Pharma
6.14.1 Astellas Pharma Corporation Information
6.14.2 Astellas Pharma Medicine for Osteoarthritis Pain Description and Business Overview
6.14.3 Astellas Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Astellas Pharma Medicine for Osteoarthritis Pain Product Portfolio
6.14.5 Astellas Pharma Recent Developments/Updates
6.15 Tide Pharmaceutical
6.15.1 Tide Pharmaceutical Corporation Information
6.15.2 Tide Pharmaceutical Medicine for Osteoarthritis Pain Description and Business Overview
6.15.3 Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Tide Pharmaceutical Medicine for Osteoarthritis Pain Product Portfolio
6.15.5 Tide Pharmaceutical Recent Developments/Updates
6.16 Iroko Pharmaceuticals
6.16.1 Iroko Pharmaceuticals Corporation Information
6.16.2 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Description and Business Overview
6.16.3 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Product Portfolio
6.16.5 Iroko Pharmaceuticals Recent Developments/Updates
6.17 Hengrui Pharmaceutical
6.17.1 Hengrui Pharmaceutical Corporation Information
6.17.2 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Description and Business Overview
6.17.3 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Product Portfolio
6.17.5 Hengrui Pharmaceutical Recent Developments/Updates
6.18 Abiogen Pharma
6.18.1 Abiogen Pharma Corporation Information
6.18.2 Abiogen Pharma Medicine for Osteoarthritis Pain Description and Business Overview
6.18.3 Abiogen Pharma Medicine for Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Abiogen Pharma Medicine for Osteoarthritis Pain Product Portfolio
6.18.5 Abiogen Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medicine for Osteoarthritis Pain Industry Chain Analysis
7.2 Medicine for Osteoarthritis Pain Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medicine for Osteoarthritis Pain Production Mode & Process
7.4 Medicine for Osteoarthritis Pain Sales and Marketing
7.4.1 Medicine for Osteoarthritis Pain Sales Channels
7.4.2 Medicine for Osteoarthritis Pain Distributors
7.5 Medicine for Osteoarthritis Pain Customers
8 Medicine for Osteoarthritis Pain Market Dynamics
8.1 Medicine for Osteoarthritis Pain Industry Trends
8.2 Medicine for Osteoarthritis Pain Market Drivers
8.3 Medicine for Osteoarthritis Pain Market Challenges
8.4 Medicine for Osteoarthritis Pain Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Medicine for Osteoarthritis Pain Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Medicine for Osteoarthritis Pain Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Medicine for Osteoarthritis Pain Market Competitive Situation by Manufacturers in 2024
Table 4. Global Medicine for Osteoarthritis Pain Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Medicine for Osteoarthritis Pain Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Medicine for Osteoarthritis Pain Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Medicine for Osteoarthritis Pain Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Medicine for Osteoarthritis Pain Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Medicine for Osteoarthritis Pain, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Medicine for Osteoarthritis Pain, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Medicine for Osteoarthritis Pain, Product Type & Application
Table 12. Global Key Manufacturers of Medicine for Osteoarthritis Pain, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Medicine for Osteoarthritis Pain by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicine for Osteoarthritis Pain as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Medicine for Osteoarthritis Pain Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Medicine for Osteoarthritis Pain Sales by Region (2018-2023) & (K Units)
Table 18. Global Medicine for Osteoarthritis Pain Sales Market Share by Region (2018-2023)
Table 19. Global Medicine for Osteoarthritis Pain Sales by Region (2024-2034) & (K Units)
Table 20. Global Medicine for Osteoarthritis Pain Sales Market Share by Region (2024-2034)
Table 21. Global Medicine for Osteoarthritis Pain Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Medicine for Osteoarthritis Pain Revenue Market Share by Region (2018-2023)
Table 23. Global Medicine for Osteoarthritis Pain Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Medicine for Osteoarthritis Pain Revenue Market Share by Region (2024-2034)
Table 25. North America Medicine for Osteoarthritis Pain Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Medicine for Osteoarthritis Pain Sales by Country (2018-2023) & (K Units)
Table 27. North America Medicine for Osteoarthritis Pain Sales by Country (2024-2034) & (K Units)
Table 28. North America Medicine for Osteoarthritis Pain Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Medicine for Osteoarthritis Pain Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Medicine for Osteoarthritis Pain Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Medicine for Osteoarthritis Pain Sales by Country (2018-2023) & (K Units)
Table 32. Europe Medicine for Osteoarthritis Pain Sales by Country (2024-2034) & (K Units)
Table 33. Europe Medicine for Osteoarthritis Pain Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Medicine for Osteoarthritis Pain Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Medicine for Osteoarthritis Pain Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Medicine for Osteoarthritis Pain Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Medicine for Osteoarthritis Pain Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Medicine for Osteoarthritis Pain Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Medicine for Osteoarthritis Pain Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Medicine for Osteoarthritis Pain Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Medicine for Osteoarthritis Pain Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Medicine for Osteoarthritis Pain Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Medicine for Osteoarthritis Pain Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Medicine for Osteoarthritis Pain Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Medicine for Osteoarthritis Pain Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Medicine for Osteoarthritis Pain Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Medicine for Osteoarthritis Pain Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Medicine for Osteoarthritis Pain Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Medicine for Osteoarthritis Pain Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Medicine for Osteoarthritis Pain Sales (K Units) by Type (2018-2023)
Table 51. Global Medicine for Osteoarthritis Pain Sales (K Units) by Type (2024-2034)
Table 52. Global Medicine for Osteoarthritis Pain Sales Market Share by Type (2018-2023)
Table 53. Global Medicine for Osteoarthritis Pain Sales Market Share by Type (2024-2034)
Table 54. Global Medicine for Osteoarthritis Pain Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Medicine for Osteoarthritis Pain Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Medicine for Osteoarthritis Pain Revenue Market Share by Type (2018-2023)
Table 57. Global Medicine for Osteoarthritis Pain Revenue Market Share by Type (2024-2034)
Table 58. Global Medicine for Osteoarthritis Pain Price (USD/Unit) by Type (2018-2023)
Table 59. Global Medicine for Osteoarthritis Pain Price (USD/Unit) by Type (2024-2034)
Table 60. Global Medicine for Osteoarthritis Pain Sales (K Units) by Application (2018-2023)
Table 61. Global Medicine for Osteoarthritis Pain Sales (K Units) by Application (2024-2034)
Table 62. Global Medicine for Osteoarthritis Pain Sales Market Share by Application (2018-2023)
Table 63. Global Medicine for Osteoarthritis Pain Sales Market Share by Application (2024-2034)
Table 64. Global Medicine for Osteoarthritis Pain Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Medicine for Osteoarthritis Pain Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Medicine for Osteoarthritis Pain Revenue Market Share by Application (2018-2023)
Table 67. Global Medicine for Osteoarthritis Pain Revenue Market Share by Application (2024-2034)
Table 68. Global Medicine for Osteoarthritis Pain Price (USD/Unit) by Application (2018-2023)
Table 69. Global Medicine for Osteoarthritis Pain Price (USD/Unit) by Application (2024-2034)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Pfizer Medicine for Osteoarthritis Pain Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Johnson and Johnson Corporation Information
Table 76. Johnson and Johnson Description and Business Overview
Table 77. Johnson and Johnson Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Johnson and Johnson Medicine for Osteoarthritis Pain Product
Table 79. Johnson and Johnson Recent Developments/Updates
Table 80. GlaxoSmithKline Corporation Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. GlaxoSmithKline Medicine for Osteoarthritis Pain Product
Table 84. GlaxoSmithKline Recent Developments/Updates
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Bayer Medicine for Osteoarthritis Pain Product
Table 89. Bayer Recent Developments/Updates
Table 90. Eli Lilly Corporation Information
Table 91. Eli Lilly Description and Business Overview
Table 92. Eli Lilly Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Eli Lilly Medicine for Osteoarthritis Pain Product
Table 94. Eli Lilly Recent Developments/Updates
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Novartis Medicine for Osteoarthritis Pain Product
Table 99. Novartis Recent Developments/Updates
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Sanofi Medicine for Osteoarthritis Pain Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Horizon Pharma Corporation Information
Table 106. Horizon Pharma Description and Business Overview
Table 107. Horizon Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Horizon Pharma Medicine for Osteoarthritis Pain Product
Table 109. Horizon Pharma Recent Developments/Updates
Table 110. Abbott Corporation Information
Table 111. Abbott Description and Business Overview
Table 112. Abbott Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Abbott Medicine for Osteoarthritis Pain Product
Table 114. Abbott Recent Developments/Updates
Table 115. Mylan Corporation Information
Table 116. Mylan Description and Business Overview
Table 117. Mylan Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Mylan Medicine for Osteoarthritis Pain Product
Table 119. Mylan Recent Developments/Updates
Table 120. Daiichi Sankyo Corporation Information
Table 121. Daiichi Sankyo Description and Business Overview
Table 122. Daiichi Sankyo Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Daiichi Sankyo Medicine for Osteoarthritis Pain Product
Table 124. Daiichi Sankyo Recent Developments/Updates
Table 125. TEVA Corporation Information
Table 126. TEVA Description and Business Overview
Table 127. TEVA Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. TEVA Medicine for Osteoarthritis Pain Product
Table 129. TEVA Recent Developments/Updates
Table 130. Almatica Pharma Corporation Information
Table 131. Almatica Pharma Description and Business Overview
Table 132. Almatica Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Almatica Pharma Medicine for Osteoarthritis Pain Product
Table 134. Almatica Pharma Recent Developments/Updates
Table 135. Astellas Pharma Corporation Information
Table 136. Astellas Pharma Description and Business Overview
Table 137. Astellas Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Astellas Pharma Medicine for Osteoarthritis Pain Product
Table 139. Astellas Pharma Recent Developments/Updates
Table 140. Tide Pharmaceutical Corporation Information
Table 141. Tide Pharmaceutical Description and Business Overview
Table 142. Tide Pharmaceutical Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Tide Pharmaceutical Medicine for Osteoarthritis Pain Product
Table 144. Tide Pharmaceutical Recent Developments/Updates
Table 145. Iroko Pharmaceuticals Corporation Information
Table 146. Iroko Pharmaceuticals Description and Business Overview
Table 147. Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Iroko Pharmaceuticals Medicine for Osteoarthritis Pain Product
Table 149. Iroko Pharmaceuticals Recent Developments/Updates
Table 150. Hengrui Pharmaceutical Corporation Information
Table 151. Hengrui Pharmaceutical Description and Business Overview
Table 152. Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Hengrui Pharmaceutical Medicine for Osteoarthritis Pain Product
Table 154. Hengrui Pharmaceutical Recent Developments/Updates
Table 155. Abiogen Pharma Corporation Information
Table 156. Abiogen Pharma Description and Business Overview
Table 157. Abiogen Pharma Medicine for Osteoarthritis Pain Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. Abiogen Pharma Medicine for Osteoarthritis Pain Product
Table 159. Abiogen Pharma Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Medicine for Osteoarthritis Pain Distributors List
Table 163. Medicine for Osteoarthritis Pain Customers List
Table 164. Medicine for Osteoarthritis Pain Market Trends
Table 165. Medicine for Osteoarthritis Pain Market Drivers
Table 166. Medicine for Osteoarthritis Pain Market Challenges
Table 167. Medicine for Osteoarthritis Pain Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Medicine for Osteoarthritis Pain
Figure 2. Global Medicine for Osteoarthritis Pain Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Medicine for Osteoarthritis Pain Market Share by Type in 2024 & 2034
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. External Product Picture
Figure 7. Global Medicine for Osteoarthritis Pain Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Medicine for Osteoarthritis Pain Market Share by Application in 2024 & 2034
Figure 9. Medical Care
Figure 10. Personal Care
Figure 11. Global Medicine for Osteoarthritis Pain Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Medicine for Osteoarthritis Pain Market Size (2018-2034) & (US$ Million)
Figure 13. Global Medicine for Osteoarthritis Pain Sales (2018-2034) & (K Units)
Figure 14. Global Medicine for Osteoarthritis Pain Average Price (USD/Unit) & (2018-2034)
Figure 15. Medicine for Osteoarthritis Pain Report Years Considered
Figure 16. Medicine for Osteoarthritis Pain Sales Share by Manufacturers in 2024
Figure 17. Global Medicine for Osteoarthritis Pain Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest Medicine for Osteoarthritis Pain Players: Market Share by Revenue in 2024
Figure 19. Medicine for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 20. Global Medicine for Osteoarthritis Pain Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 21. North America Medicine for Osteoarthritis Pain Sales Market Share by Country (2018-2034)
Figure 22. North America Medicine for Osteoarthritis Pain Revenue Market Share by Country (2018-2034)
Figure 23. U.S. Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Medicine for Osteoarthritis Pain Sales Market Share by Country (2018-2034)
Figure 26. Europe Medicine for Osteoarthritis Pain Revenue Market Share by Country (2018-2034)
Figure 27. Germany Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Medicine for Osteoarthritis Pain Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Medicine for Osteoarthritis Pain Revenue Market Share by Region (2018-2034)
Figure 34. China Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Taiwan Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Philippines Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Medicine for Osteoarthritis Pain Sales Market Share by Country (2018-2034)
Figure 45. Latin America Medicine for Osteoarthritis Pain Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Medicine for Osteoarthritis Pain Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Medicine for Osteoarthritis Pain Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. UAE Medicine for Osteoarthritis Pain Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Medicine for Osteoarthritis Pain by Type (2018-2034)
Figure 55. Global Revenue Market Share of Medicine for Osteoarthritis Pain by Type (2018-2034)
Figure 56. Global Medicine for Osteoarthritis Pain Price (USD/Unit) by Type (2018-2034)
Figure 57. Global Sales Market Share of Medicine for Osteoarthritis Pain by Application (2018-2034)
Figure 58. Global Revenue Market Share of Medicine for Osteoarthritis Pain by Application (2018-2034)
Figure 59. Global Medicine for Osteoarthritis Pain Price (USD/Unit) by Application (2018-2034)
Figure 60. Medicine for Osteoarthritis Pain Value Chain
Figure 61. Medicine for Osteoarthritis Pain Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed